Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A new mechanism of nervous system plasticity: activity-dependent myelination.
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy.
Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health.
Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Experiences of hospitalization in patients with multiple sclerosis: A qualitative study.
Simvastatin in patients with progressive multiple sclerosis.
[Disease modifying drugs in multiple sclerosis and pregnancy.]
A case of acute disseminated encephalomyelitis disguised as mania in a woman with known bipolar disorder.
Eight-and-a-half syndrome as presenting sign of childhood multiple sclerosis.
Persistence and pathogenesis of the neurotropic polyomavirus JC.
[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.
Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
Neurodegeneration in multiple sclerosis: novel treatment strategies.
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.
Epigenetic changes in inflammatory and autoimmune diseases.
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden.
Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.
Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases.

Pages